Ottawa – Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, respiratory syncytial virus (RSV), and norovirus—and its risk to public health, according to the Centers for Disease Control and Prevention (CDC), remains low. But that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even probable. The Department of Health and Human Services (HHS), of which the …
Washington – At Moderna, we are delivering on the promise of mRNA science to create a new generation of transformative medicines for patients. An mRNA can teach the body how to make a specific protein that can help your immune system prevent or treat certain diseases. Scientists have been studying mRNA for decades. And mRNA vaccines are just the start. Your body contains trillions of cells, …
CAMBRIDGE-Moderna announced Health Canada has approved mRESVIA™ (Respiratory Syncy-al Virus mRNA vaccine) for ac-ve immuniza-on for the preven-on of lower respiratory tract disease caused by respiratory syncy-al virus (RSV) in adults 60 years of age and older.1 “This approval is an example of how our mRNA platform can help address significant public health challenges like RSV,” said Stéphane Bancel, Chief …
Washington – Moderna said: “At Moderna, we are delivering on the promise of mRNA science to create a new generation of transformative medicines for patients. An mRNA can teach the body how to make a specific protein that can help your immune system prevent or treat certain diseases. Scientists have been studying mRNA for decades. And mRNA vaccines are just the start. Your body contains trillions …
LAVAL – Moderna has completed construction of its state-of-the art mRNA manufacturing facility in Laval, Quebec. The facility is expected to be ready to manufacture respiratory mRNA vaccines for Canadians in 2025, pending regulatory approvals and certifications, ensuring all vaccines manufactured meet the strictest quality, safety and performance standards. The construction of this facility marks an important milestone in Moderna’s …
Laval – In June 2022, the Government of Canada established a long-term agreement with Moderna for the domestic production of messenger RNA (mRNA) vaccines in Canada. The negotiations began in 2021, during the depths of the COVID-19 pandemic, as the country faced intense global competition to secure vaccines. This global supply chain vulnerability showcased the need to ensure domestic capacity …
Washington – At Moderna, experts say they are delivering on the promise of mRNA science to create a new generation of transformative medicines for patients. An mRNA can teach the body how to make a specific protein that can help your immune system prevent or treat certain diseases. Scientists have been studying mRNA for decades. And mRNA vaccines are just the start. Your body contains trillions …
TORONTO — Ontario is reminding everyone to stay safe this respiratory illness season and prevent unnecessary visits to the hospital by staying up to date on vaccinations. Ontarians are encouraged to get their flu and COVID-19 shots as soon as they are available to them. “Our government is making sure Ontarians can connect to tools they need to keep themselves …
Washington – Moderna said its clinical trial data showed its updated Covid-19 vaccine can effective against the highly-mutated BA.2.86 subvariant that has raised fears of a resurgence of infections. Moderna head of infectious diseases Jacqueline Miller said in an interview: “We think this is news people will want to hear as they prepare to go out and get their fall …
Vaccines manufactured at Moderna’s state-of-the-art Canadian mRNA facility to be prepared and packaged at Novocol’s Ontario-based facility Fill-finish agreement will secure domestic end-to-end vaccine production and ensures rapid response capabilities for future pandemic readiness for Canadians TORONTO-Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a long-term agreement with Ontario-based Novocol Pharma, a leading …
